Background: Mistletoe extracts are widely used in cancer
patients due to their cytostatic and immunomodulatory effects.
Essential components include mistletoe lectins which
act as biomodulators with proinflammatory and apoptosisinducing
effects. This study investigates the acute and longterm
effects of standardized mistletoe extract (Iscador® M
spec 5 mg) on thymocyte subpopulations and peripheral
T-cells using a murine (Balb/c) model. Materials and Methods:
Using cell surface CD4/CD8 staining and flow cytometry,
we followed the changes in CD4-CD8- double-negative
(DN), CD4+CD8+ double-positive (DP) and CD4+ or CD8+
single-positive (SP) T-cells 24 h after single or repeated injections
of 3 different dilutions (1:12, 1:60, 1:300) corresponding
to 2.1, 0.42 and 0.08 mg/kg of Iscador. Thymocyte
apoptosis was detected by flow cytometry using Annexin V
and propidium iodide. Results: 24 h after a single injection
of the 2 lower doses, the number of DN thymocytes increased
significantly with an enhanced ratio of apoptotic
cells. Following administration of the lowest dose, in peripheral
blood the CD4+/CD8+ ratio was elevated. In the
long-term trial, Balb/c mice were treated twice a week with
3 different doses of Iscador +/- 20 mg/kg of dexamethasone
(DX), resulting in significantly enhanced DN thymocytes and
elevated levels of apoptotic cells after treatment with the
2 lower doses. Iscador also inhibited the DX-induced reduction
in the thymic DN cell count, as well as the DX-induced
decrease in the CD4+/CD8+ ratio and CD4+ in the peripheral
blood. Conclusion: Our results suggest that standardized
mistletoe extract modulates proliferation and apoptosis of
thymocytes in a dose-dependent manner and may act lymphoprotective
during DX treatment.